ClinicalTrials.gg
CompletedNCT05176743FIOncUpdated Oct 5, 2022

Food Insecurity in Oncology

An interventional study of Unconditional Cash Transfer (UCT) in Food Insecurity and Cancer, sponsored by New Mexico Cancer Research Alliance. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-05.

Sponsored by New Mexico Cancer Research Alliance · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This trial will examine the feasibility and preliminary effectiveness of providing unconditional cash transfers to food insecure female breast and gynecologic cancer patients.

Approximately one-third of cancer survivors report food insecurity, characterized by limited access to adequate food for active, healthy living because of a lack of money and other resources. Unconditional cash transfers offer direct monetary assistance that can be used to meet immediate food or other financial needs and may positively impact health care resource utilization and health-related quality of life.

Read the detailed description

In this delayed intervention trial, 44 female breast and gynecologic cancer patients experiencing food insecurity will be randomized in a 1:1 ratio to receive unconditional cash transfers (UCT) for 3 months or an equivalent one-time UCT at the end of the study.

Quantitative surveys will be administered at baseline and after 3-months. Survey measures will include questions about health care resource utilization, health-related quality of life, food security, hospitalization use, emergency department use, and mental health. The main objective for this pilot trial is to assess feasibility. The investigators will measure whether the investigators can: recruit 44 food insecure participants meeting the eligibility criteria over a 3-month recruitment window and describe the barriers and facilitators of the recruitment process. The investigators will also monitor retention and survey completion. At the end of the 3 month follow-up period, all participants will complete a semi-structured exit interview.

02

Conditions studied

  • Food Insecurity
  • Cancer

Browse trials for

03

In context

Neoplasms

9,617 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.

This study's enrollment of 44 is below the median of 50 across 7,432 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

New Mexico Cancer Research Alliance is the lead sponsor of 72 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of female breast (ICD-10 C50), ovarian (ICD-10 C56), endometrial (ICD-10 C54), cervical (ICD-10 C53), vulvar cancer (ICD-10 C51)
  • Diagnosed within 24-months of identification
  • Stage I-III
  • Completed initial course of cancer directed therapy (surgery, radiation, chemotherapy).
  • Age ≥18
  • Able to speak English or Spanish
  • Food insecure

Exclusion criteria

Exclusion Criteria:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Prisoners
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Other
    Usual Care

    * Referral to services * Nutrition pamphlets * One-time payment of $300 paid 4 months after baseline

    Behavioral: Unconditional Cash Transfer (UCT)

  • Experimental
    Unconditional Cash Transfer Intervention

    * Three monthly payments of $100 * Referral to services * Nutrition pamphlets

    Behavioral: Unconditional Cash Transfer (UCT)

Interventions

  • BehavioralUnconditional Cash Transfer (UCT)

    The UCT consists of three $100 VISA merchandise cards provided monthly via mail to participants randomized to the intervention arm. Merchandise cards can be used anywhere that VISA is accepted. Participants in the UCT arm will also receive Usual Care, including referral to the patient support services team and nutritional pamphlets.

06

What researchers measure

Primary outcomes

  1. Determine the percentage of referred patients who are eligible to enroll in the study and choose to do so

    Time frame: 3 months

  2. Determine the percentage of patients who complete both the baseline and 3 month follow-up survey

    Time frame: 3 months

  3. Determine the number of participants who complete the surveys

    Time frame: 3 months

Secondary outcomes

  1. Assess healthcare resource utilization using the PhenX-Access to Health Services toolkit

    Time frame: 3 months

  2. Healthcare costs

    Time frame: 3 months

  3. Assess health-related quality of life using the PROMIS Global Health 10 item questionnaire

    Nine of the Global Health PROMIS measures items are scored on a Likert scale, with 1 representing the worst health situation and 5 representing the best health situation. Pain is scored from 0 to 10 with 0 indicating no pain and 10 representing the worst pain ever experienced. Two sub-scores can also be derived from the 10 item questionnaire to assess physical and mental health separately. Raw scores must be converted to a standardized T-score for interpretation. A higher PROMIS T-score indicates a person whose health is better than the average respondent.

    Time frame: 3 months

  4. Assess the number of participants who are food insecure using the Hunger VitalSign food insecurity screening tool

    Time frame: 3 months

  5. Determine the number of patients who use the Emergency Department during the 3 month follow-up period as well as how many visits they have

    Time frame: 3 months

  6. Determine the number of patients who report being hospitalized during the 3 month follow-up period as well as the number of times they are hospitalized

    Time frame: 3 months

  7. Assess number of participants experiencing depression using the Patient Health Questionnaire (PHQ-9) screener tool

    Time frame: 3 months

  8. Assess participants perceived self-efficacy using the PROMIS Self-Efficacy for Managing Medications and Treatments 4a questionnaire

    The 4 questions that comprise this measure are measured on a Likert scale with 1 representing that the respondent is "not at all confident" completing the described task and 5 representing that the respondent is "very confident" completing the task. Raw scores range from 4-20, but T-score conversions are needed for interpretation. A higher PROMIS T-score indicates a person whose health is better than the average respondent.

    Time frame: 3 months

  9. Assess incidence of participant stress using the Perceived Stress Scale (PSS-10)

    Time frame: 3 months

07

Study locations

1 site
  • University of New Mexico Comprehensive Cancer Center
    Albuquerque, New Mexico 87102, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05176743
Lead sponsor
New Mexico Cancer Research Alliance
Collaborators
University of New Mexico Cancer Center, Wake Forest University Health Sciences, National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Jan 4, 2022
Start date
Aug 30, 2021
Primary completion
Mar 2, 2022
Completion
Jun 20, 2022
Last update
Oct 5, 2022

Study contacts

Jean A McDougall, PhD, MPH
principal investigator · University of New Mexico, Internal Medicine/Epidemiology, Biostatistics & Preventive Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion